Omadacycline Injection and PediaCare Children’s Multi-Symptom
Determining the interaction of Omadacycline Injection and PediaCare Children’s Multi-Symptom and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
Generic Name: dextromethorphan / phenylephrine
Brand name: Children's Triacting Daytime, PediaCare Children's Multi-Symptom Cold, Safetussin CD, Sudafed PE Children's Cold & Cough, Triaminic Day Time Cold & Cough, Albatussin Pediatric, Pedia Care Multi-Symptom Cold, PediaCare Childrenâs Multi-Symptom, Sudafed PE Cold & Cough Child, Triacting Day Time Cold/Cough, Vicks Formula 44D Cough & Sinus Congestion Relief, Triaminic Daytime Cough & Cold, Triaminic Thin Strips Cough and Congestion, Triaminic Toddler Cough and Cold Thin Strips, Dimetapp Cold & Cough, Triaminic Thin Strips Infant Decongestant Plus Cough, PediaCare Infant Decongestant & Cough
Synonyms: PediaCare Children's Multi-Symptom Cold
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omadacycline Injection-PediaCare Cold/Allergy
- Omadacycline Injection-Pediacare Decongestant Infants
- Omadacycline Injection-Pediacare Long-Acting Cough
- Omadacycline Injection-Pediaderm HC
- Omadacycline Injection-Pediaderm HC Kit
- Omadacycline Injection-Pediaderm TA
- PediaCare Children’s Multi-Symptom-Omadacycline Intravenous
- PediaCare Children’s Multi-Symptom-Omadacycline oral/injection
- PediaCare Children’s Multi-Symptom-Omadacycline Tablets
- PediaCare Children’s Multi-Symptom-Omadacycline Tosylate
- PediaCare Children’s Multi-Symptom-Omalizumab
- PediaCare Children’s Multi-Symptom-Omalizumab Subcutaneous